www.cbthera.com Open in urlscan Pro
35.232.176.17  Public Scan

Submitted URL: http://www.cbthera.com/
Effective URL: https://www.cbthera.com/
Submission: On December 03 via api from US — Scanned from DE

Form analysis 1 forms found in the DOM

https://www.cbthera.com/wp-admin/admin-ajax.php?action=brizy_submit_form

<form class="brz-form brz-d-xs-flex brz-flex-xs-wrap" action="https://www.cbthera.com/wp-admin/admin-ajax.php?action=brizy_submit_form" novalidate="" data-form-id="hrwoaxiaqizosgtmjlfaijpyefehwgsnmrjo"
  data-project-id="e2f36b47f53a8175eb33d040ee575bd5" data-success="" data-error="" data-redirect="https://www.cbthera.com/success">
  <div class="brz-forms2__item brz-css-npftu brz-css-uouau"><input type="email" id="mzawrubivkzyecvjdoznymcpmhjmmpjvivyh" name="ulhidbflmnytxpalozaennmdzncwpkkrtpws" placeholder="Email" required=""
      pattern="^(([^<>()\[\]\\.,;:\s@&quot;]+(\.[^<>()\[\]\\.,;:\s@&quot;]+)*)|(&quot;.+&quot;))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$" data-type="Email" data-label="Email" data-placeholder="Email"
      class="brz-input brz-forms2__field brz-forms2__field-email"></div>
  <div class="brz-forms2__item brz-css-npftu brz-d-none brz-css-uouau"><input type="hidden" id="byuzcxjxmjqufoulhnqzdlmfyvsybclduwvz" name="dhhhthvhnoukchqhnrtvigxurueyuwkjohne" placeholder="Connect With Us Form Fillout" data-type="Hidden"
      data-label="Connect With Us Form Fillout" data-placeholder="Connect With Us Form Fillout" class="brz-input brz-forms2__field brz-forms2__field-hidden"></div>
  <div class="brz-forms2 brz-forms2__item brz-forms2__item-button">
    <button class="brz-btn brz-btn-submit brz-css-gkqlx brz-css-qoxtg" data-custom-id="ylskcblqrsxohkhjwmjzyuucaaxuavlnsabw"><svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
        viewBox="0 0 24 24" xml:space="preserve" class="brz-icon-svg brz-css-jvlge brz-css-wehvv" data-type="glyph" data-name="tail-right">
        <g class="nc-icon-wrapper" fill="currentColor">
          <path fill="currentColor" d="M22.707,11.293L15,3.586L13.586,5l6,6H2c-0.553,0-1,0.448-1,1s0.447,1,1,1h17.586l-6,6L15,20.414 l7.707-7.707C23.098,12.316,23.098,11.684,22.707,11.293z"></path>
        </g>
      </svg><span class="brz-span brz-text__editor">CONNECT WITH US</span><svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 24 24" xml:space="preserve"
        class="brz-icon-svg brz-form-spinner brz-invisible brz-ed-animated--spin" data-type="glyph" data-name="circle-02">
        <g class="nc-icon-wrapper" fill="currentColor">
          <g class="nc-loop_circle-02-24" transform="rotate(212.24285714285674 12 12)">
            <path opacity="0.4" fill="currentColor" d="M12,24C5.3833008,24,0,18.6166992,0,12S5.3833008,0,12,0s12,5.3833008,12,12 S18.6166992,24,12,24z M12,2C6.4858398,2,2,6.4858398,2,12s4.4858398,10,10,10s10-4.4858398,10-10S17.5141602,2,12,2z">
            </path>
            <path data-color="color-2" fill="currentColor" d="M24,12h-2c0-5.5141602-4.4858398-10-10-10V0C18.6166992,0,24,5.3833008,24,12z"></path>
          </g>
          <script>
            ! function() {
              function t(t) {
                this.element = t, this.animationId, this.start = null, this.init()
              }
              if (!window.requestAnimationFrame) {
                var i = null;
                window.requestAnimationFrame = function(t, n) {
                  var e = (new Date).getTime();
                  i || (i = e);
                  var a = Math.max(0, 16 - (e - i)),
                    o = window.setTimeout(function() {
                      t(e + a)
                    }, a);
                  return i = e + a, o
                }
              }
              t.prototype.init = function() {
                var t = this;
                this.animationId = window.requestAnimationFrame(t.triggerAnimation.bind(t))
              }, t.prototype.reset = function() {
                var t = this;
                window.cancelAnimationFrame(t.animationId)
              }, t.prototype.triggerAnimation = function(t) {
                var i = this;
                this.start || (this.start = t);
                var n = t - this.start;
                504 & gt;
                n || (this.start = this.start + 504), this.element.setAttribute("transform", "rotate(" + Math.min(n / 1.4, 360) + " 12 12)");
                if (document.documentElement.contains(this.element)) window.requestAnimationFrame(i.triggerAnimation.bind(i))
              };
              var n = document.getElementsByClassName("nc-loop_circle-02-24"),
                e = [];
              if (n)
                for (var a = 0; n.length & gt; a; a++) ! function(i) {
                  e.push(new t(n[i]))
                }(a);
              document.addEventListener("visibilitychange", function() {
                "hidden" == document.visibilityState ? e.forEach(function(t) {
                  t.reset()
                }) : e.forEach(function(t) {
                  t.init()
                })
              })
            }();
          </script>
        </g>
      </svg></button>
  </div>
</form>

Text Content

Menu
 * Platform ⇣Toggle submenu
    * Our Platform
    * Psychedelics
    * Cannabinoids
    * Food Tech
    * Environmental Benefits

 * Team
 * Partnerships
 * Resources ⇣Toggle submenu
    * News Archive

 * Contact ⇣Toggle submenu
    * Careers

 * Invest in CBThera

Menu
 * Platform ⇣Toggle submenu
    * Our Platform
    * Psychedelics
    * Cannabinoids
    * Food Tech
    * Environmental Benefits

 * Team
 * Partnerships
 * Resources ⇣Toggle submenu
    * News Archive

 * Contact ⇣Toggle submenu
    * Careers

 * Invest in CBThera

 * Platform ⇣
   * Our Platform
   * Psychedelics
   * Cannabinoids
   * Food Tech
   * Environmental Benefits
 * Team
 * Partnerships
 * Resources ⇣
   * News Archive
 * Contact ⇣
   * Careers
 * Invest in CBThera


 * Platform ⇣
   * Our Platform
   * Psychedelics
   * Cannabinoids
   * Food Tech
   * Environmental Benefits
 * Team
 * Partnerships
 * Resources ⇣
   * News Archive
 * Contact ⇣
   * Careers
 * Invest in CBThera



PSYCHEDELICS

CANNABINOIDS

FOOD TECH

Advanced Synthetic Biology For Planet and Human Health

CB Therapeutics is leading the synthetic biology revolution for producing
next-generation research molecules and animal-free ingredients. We create
sustainable, innovative bio-manufacturing solutions to supply diverse industries
from clinical research and nutraceuticals, to cosmetics and the food and
beverage markets.

thin

Biosynthesis is a highly scalable process that has been used for several years
in multiple sectors.

Compared to traditional methods of production, biosynthesis offers ways to
reduce the environmental footprint, decrease production time.

Additionally, biosynthesis standardizes the production of high-quality
psychedelics, cannabinoids, animal-free food ingredients, and much more.

Biosynthesis is a highly scalable process that has been used for several years
in multiple sectors.

Compared to traditional methods of production, biosynthesis offers ways to
reduce the environmental footprint, decrease production time.

Additionally, biosynthesis standardizes the production of high-quality
psychedelics, cannabinoids, animal-free food ingredients, and much more.

Biosynthesis is a highly scalable process that has been used for several years
in multiple sectors.

thin
 * 1
 * 2
 * 3


OUR PRODUCTION CAPACITY

CB Therapeutics is trailblazing the creation of new opportunities for
therapeutic solutions involving:



Phytocannabinoids

Cannabinoid analogs

Terpenes



Tryptamines (psychedelics)

Tryptamine analogs (psychedelics)

Other psychedelics



Food Tech

Cellular Agriculture

Novel Food Additives





GROUNDBREAKING SCIENCE POWERED BY YEAST.

We use a cutting-edge proprietary yeast platform that enhances natural metabolic
processes through precision fermentation to produce a variety of compounds, from
small chemical analogs to bio-identical molecules that exactly match their
counterparts in nature. The advantage of our approach is that it delivers pure,
consistent, and reliable molecules.







Learn More

In the News.

 * July 21, 2022
 * June 20, 2022
 * April 25, 2022
 * December 20, 2021
 * December 9, 2021
 * August 24, 2021
 * May 10, 2021
 * September 23, 2020

July 21, 2022

MAY 19, 2022


TO TACKLE SUSTAINABLE FOOD AND ACTIVE INGREDIENT MANUFACTURING, CB THERAPEUTICS
IS DEVELOPING ECO-CONSCIOUS SOLUTIONS THROUGH PRECISION FERMENTATION

CARLSBAD, Calif., July 21, 2022 — CB Therapeutics (the "Company"), a
biosynthesis company focused on creating ethically-produced,
environmentally-friendly products for human health, has successfully developed
various food tech prototypes using its next-gen synbio and precision
fermentation platform. Now, the Company is looking for partnerships in the food
technology and active ingredient spaces that align with its value propositions.

READ MORE
June 20, 2022

MAY 19, 2022


CB THERAPEUTICS’ BUSINESS DEVELOPMENT LEAD, TIFFANY HURD, IS FURTHER BRIDGING
THE GAP BETWEEN PHARMA AND PSYCHEDELICS

CARLSBAD, Calif., June 20, 2022 (GLOBE NEWSWIRE) — CB Therapeutics (the
"Company"), a biosynthesis company focused on creating ethically-produced,
environmentally-friendly products for human health, welcomes a new member of the
team who is focused on growth and sustainability.

READ MORE
April 25, 2022

APRIL 25, 2022


CB THERAPEUTICS RAPIDLY EXPANDS CELLULAR AGRICULTURE CAPABILITIES AT NEW
FACILITY

CARLSBAD, Calif., April 25, 2022 (GLOBE NEWSWIRE) — CB Therapeutics (the
“Company”), a biosynthesis company focused on creating ethically-produced,
environmentally-friendly products for human health, is celebrating a move to an
expanded laboratory, which will serve to

increase its research compound production footprint.

READ MORE
December 20, 2021

DECEMBER 20, 2021


TWO ESTEEMED DOCTORS JOIN CB THERAPEUTICS IN ITS EXPLORATION OF INNOVATIVE
APPROACHES TO THE PRODUCTION OF NOVEL PSYCHEDELICS AND CANNABINOIDS SO
RESEARCHERS CAN ADDRESS THE UNMET NEEDS OF PATIENT COMMUNITIES

SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) — CB Therapeutics today announces the
appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed
Medical Advisory Board.

READ MORE
December 9, 2021

DECEMBER 9, 2021


CB THERAPEUTICS AND ATAI LIFE SCIENCES LAUNCH TRYPTAGENIX TO SUSTAINABLY SUPPLY
AND DEVELOP CLINICALLY RELEVANT COMPOUNDS TO TACKLE THE GROWING MENTAL HEALTH
CRISIS

SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) — CB Therapeutics, a biosynthesis
company focused on creating ethical and environmentally-friendly products to
improve mental health and increase healthspan, believes their partnership with
atai Life Sciences will help to meet the growing unmet needs of patients with
mental health conditions.

READ MORE
August 24, 2021

AUGUST 24, 2021


CB THERAPEUTICS ACHIEVES ANOTHER BREAKTHROUGH WITH THE BIOSYNTHESIS OF DMT AND
RELATED TRYPTAMINE-BASED COMPOUNDS

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is happy to announce that it has been
awarded two more patents for the novel methods of production of high value
molecules using cutting-edge biosynthesis technologies. These patents
(11,041,002B1 and 10,988,785B1) cover inventions on cellular agriculture
breakthroughs for producing cannabinoids and precursors to various other
compounds…

READ MORE
May 10, 2021

MAY 10, 2021


CB THERAPEUTICS CLOSES ON OVERSUBSCRIBED SERIES A

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., the leading synthetic biology
company focused on the development and biosynthetic production of existing and
novel tryptamines and cannabinoids, is pleased to announce that it has closed an
oversubscribed Series A funding round, filled entirely by re.Mind Capital, a
fund launched by the psychedelics kingmaker, Christian Angermayer within
Apeiron, his family office…

READ MORE
September 23, 2020

SEPTEMBER 23, 2020


CB THERAPEUTICS ACHIEVES MAJOR BREAKTHROUGHS IN DOWNSTREAM PROCESSING AND
PURIFICATION, PAVING THE WAY FOR LOW-COST CANNABINOIDS, TRYPTAMINES, AND THEIR
ANALOGS

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., has successfully refined its
in-house downstream processing, allowing for 99.6% pure CBC. a rare cannabinoid
molecule found in trace quantities in cannabis and hemp. Using these
patent-pending techniques, CB Therapeutics is able to drive down the cost of
purification in parallel with increasing the purity to over 99%, considered a
major breakthrough for any type of purification process…

READ MORE
SEE OUR NEWS ARCHIVE FOR EARLIER ACHIEVEMENTS


Our Blog.

Read Our Latest Posts

December 8, 2021

Welcome to the new CB Therapeutics Website
READ MORE

Our Platform

Platform ▼

➔ Psychedelics

➔ Cannabinoids

➔ Food Tech

➔ Environmental Sustainability

Other Pages

Team

Partnerships

Resources ▼

➔ News Archive

Contact ▼

➔ Careers

Privacy Policy
Cookie Policy

Call us now at:

+1 (833) 322-8437


CONNECT WITH US
Close menu

×
Notice

We and selected third parties use cookies or similar technologies for technical
purposes and, with your consent, for other purposes as specified in the cookie
policy. Denying consent may make related features unavailable.



Use the “Accept” button or close this notice to consent to the use of such
technologies.

Press again to continue 0/1
Learn more
Accept